Ivm Health operates as a telehealth coordination platform connecting patients with licensed healthcare providers for GLP-1 weight loss treatment
Board Certified GastroenterologistBoard Certified GastroenterologistExpert AnswerLactose intolerance can cause tremendous gas
With FDA approval of oral semaglutide for weight management, GLP-1 therapy becomes easier to prescribe, easier to distribute, and easier to imagine as part of routine primary care
PMID 16984231
This review seeks to provide further clinical context both to assist in the creation of future high-quality evidence and guidelines as well as to assist providers in making informed, evidence-driven decision to enhance outcomes and minimize risks in the perioperative period for this patient population
According to the FDA prescribing information for tirzepatide, constipation is reported as a common gastrointestinal adverse effect, though it occurs less frequently than nausea, diarrhea, and vomiting